Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Wareham › NPI 1922024835
Hospital

Southcoast Hospitals Group, INC

Southcoast Hospitals Group, INC was paid $26.22M by Medicaid between Jan 2018 and Dec 2024, across 231 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.

33Billing provider infoSOUTHCOAST HOSPITALS GROUP, INC
WAREHAM, MA 02571
33aNPI1922024835assigned 07/14/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$26.22M
24GClaims632,383
24DCodes billed231
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Massachusetts

Rank by total paid#36 of 66
Median peer was paid$29.11M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201896,658$4.34M
201995,066$4.07M
202071,860$2.60M
202190,439$3.34M
202289,327$4.07M
2023101,990$4.31M
2024incomplete87,043$3.49M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 24,941 22,972 $4.16M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 20,352 18,651 $3.13M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 18,196 16,420 $2.85M
96361 Intravenous infusion, hydration; each additional hour 11% 8,132 7,368 $2.78M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 7.5% 24,904 7,616 $1.97M
G0378 Hospital observation service, per hour 7.2% 12,702 6,593 $1.88M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.2% 5,039 4,790 $828K
70450 Computed tomography, head or brain; without contrast material 2.4% 5,579 5,187 $630K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 4,580 4,112 $492K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.8% 3,638 3,461 $480K
S9485 Crisis intervention mental health services, per diem 1.8% 895 660 $466K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 2,114 2,024 $376K
219 more codes
64483 1.2% 722 $309K
77063 Screening digital breast tomosynthesis, bilateral 1.1% 3,773 $286K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.1% 7,448 $282K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.1% 1,856 $277K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.0% 4,382 $275K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,143 $219K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 44,123 $207K
80053 Comprehensive metabolic panel <1% 42,079 $205K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,085 $194K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 5,095 $193K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,055 $169K
71046 Radiologic examination, chest; 2 views <1% 8,186 $166K
97161 <1% 1,992 $144K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,159 $142K
76830 Ultrasound, transvaginal <1% 1,092 $128K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,204 $124K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 6,194 $122K
93971 <1% 488 $113K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 1,613 $102K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 854 $98K
83690 <1% 21,824 $97K
80050 General health panel <1% 5,077 $96K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,001 $94K
ATP14 <1% 11,018 $80K
84484 <1% 10,632 $66K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 368 $65K
84443 Thyroid stimulating hormone (TSH) <1% 7,769 $64K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,209 $62K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,186 $61K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 577 $61K
80061 Lipid panel <1% 12,899 $56K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,117 $55K
64493 <1% 99 $50K
83036 Hemoglobin; glycosylated (A1C) <1% 8,284 $48K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,858 $48K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 322 $47K
82607 <1% 4,852 $45K
84703 <1% 7,305 $44K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,709 $42K
87086 Culture, bacterial; quantitative colony count, urine <1% 7,441 $39K
86317 <1% 925 $39K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 943 $35K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 9,327 $34K
97162 <1% 773 $33K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 64 $32K
87070 <1% 4,261 $32K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 169 $30K
Q0081 Infusion therapy, using other than chemotherapeutic drugs, per visit <1% 695 $29K
84702 <1% 2,275 $28K
82746 <1% 3,206 $28K
80048 Basic metabolic panel (calcium, ionized) <1% 7,743 $28K
83970 <1% 1,109 $28K
74018 <1% 279 $27K
83735 <1% 6,449 $25K
83550 <1% 4,219 $25K
73630 <1% 826 $24K
71275 Computed tomographic angiography, chest, with contrast material <1% 68 $24K
87400 <1% 1,386 $23K
83880 <1% 1,626 $23K
99218 <1% 55 $21K
82728 <1% 2,178 $20K
91300 <1% 45 $19K
83540 <1% 4,300 $19K
85610 <1% 7,270 $19K
81001 <1% 8,892 $18K
84439 <1% 2,757 $18K
81513 <1% 158 $18K
72100 <1% 764 $17K
86618 <1% 1,312 $17K
72125 Computed tomography, cervical spine; without contrast material <1% 1,471 $16K
71045 Radiologic examination, chest; single view <1% 4,769 $16K
87186 <1% 3,120 $16K
73610 <1% 623 $15K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 698 $15K
96375 Therapeutic injection; each additional sequential IV push <1% 9,895 $15K
76642 <1% 119 $14K
85027 <1% 2,818 $13K
86803 <1% 977 $12K
59025 Fetal non-stress test <1% 48 $11K
85730 <1% 2,382 $11K
73564 <1% 559 $11K
81003 <1% 6,812 $10K
36415 Collection of venous blood by venipuncture <1% 26,128 $10K
86780 <1% 898 $10K
73130 <1% 447 $10K
87469 <1% 461 $10K
87468 <1% 462 $10K
87478 <1% 461 $10K
87484 <1% 461 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 835 $9K
87481 <1% 236 $8K
86141 <1% 808 $8K
73030 <1% 327 $7K
ATP08 <1% 2,003 $7K
87430 <1% 503 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,696 $6K
J2704 Injection, propofol, 10 mg <1% 5,068 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 205 $6K
87088 <1% 1,056 $6K
0011A <1% 347 $5K
85652 <1% 3,106 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,931 $5K
0012A <1% 333 $5K
0031A <1% 198 $5K
64484 <1% 16 $5K
87147 <1% 775 $5K
86850 <1% 610 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,677 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,740 $4K
82043 <1% 1,520 $4K
ATP17 <1% 2,869 $4K
84153 <1% 248 $4K
87450 <1% 780 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,341 $4K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 204 $3K
87340 <1% 387 $3K
83516 <1% 308 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 28 $3K
81025 <1% 428 $2K
ATP03 <1% 1,059 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 13 $2K
87077 <1% 705 $2K
73110 <1% 73 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 15 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 12 $2K
87510 <1% 122 $2K
87480 <1% 122 $2K
87040 <1% 306 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 12 $2K
83605 <1% 403 $2K
J1040 Injection, methylprednisolone acetate, 80 mg <1% 1,343 $2K
71250 <1% 102 $2K
87660 <1% 111 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 95 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,224 $2K
86900 <1% 673 $2K
86901 <1% 670 $2K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 415 $2K
86706 <1% 157 $2K
96376 <1% 493 $2K
85007 <1% 483 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,807 $1K
77080 <1% 27 $1K
0001A <1% 60 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,181 $1K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 19 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,720 $1K
82784 <1% 119 $1K
0002A <1% 52 $1K
64494 <1% 96 $1K
80076 <1% 220 $958.17
86038 <1% 86 $931.21
86704 <1% 86 $898.70
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 24 $895.49
82550 <1% 284 $894.07
70551 Magnetic resonance imaging, brain; without contrast material <1% 13 $861.68
84403 <1% 38 $842.12
90715 <1% 45 $747.48
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 164 $729.51
73502 <1% 97 $613.41
85651 <1% 229 $612.45
J1030 Injection, methylprednisolone acetate, 40 mg <1% 563 $597.69
ATP15 <1% 107 $567.60
J1170 Injection, hydromorphone, up to 4 mg <1% 673 $550.59
J2060 Injection, lorazepam, 2 mg <1% 1,475 $548.08
J1650 Injection, enoxaparin sodium, 10 mg <1% 353 $518.89
82570 <1% 217 $509.29
83001 <1% 31 $495.06
74019 <1% 14 $472.98
93000 <1% 48 $466.19
84550 <1% 183 $450.68
J1644 Injection, heparin sodium, per 1000 units <1% 129 $435.62
82962 <1% 2,936 $434.27
84460 <1% 161 $422.81
85379 <1% 51 $412.82
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 16 $394.64
82670 <1% 15 $374.65
84425 <1% 27 $341.80
86617 <1% 13 $327.84
86140 <1% 70 $318.33
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 657 $273.14
87205 <1% 76 $273.14
J0690 Injection, cefazolin sodium, 500 mg <1% 351 $254.62
84450 <1% 109 $229.88
88142 <1% 12 $214.44
83002 <1% 12 $195.96
86762 <1% 15 $190.35
96367 <1% 22 $181.65
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 265 $157.44
84100 <1% 225 $126.60
82565 <1% 53 $76.27
73080 <1% 12 $60.74
90686 <1% 39 $49.30
85045 <1% 12 $49.08
ATP16 <1% 30 $33.46
J0780 Injection, prochlorperazine, up to 10 mg <1% 17 $31.98
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 579 $25.00
82247 <1% 13 $22.80
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 438 $8.19
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 39 $5.23
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 96 $4.09
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 854 $3.92
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 224 $0.01
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 263 $0.01
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 18 $0.00
99221 0% 95 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 3,576 $0.00
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 0% 27 $0.00
99152 0% 45 $0.00
64495 0% 19 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 0% 13 $0.00
C1755 Catheter, intraspinal 0% 267 $0.00
A9573 Injection, gadopiclenol, 1 ml 0% 69 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 230 $0.00
J1790 Injection, droperidol, up to 5 mg 0% 18 $0.00
G0008 Administration of influenza virus vaccine 0% 37 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 30 $0.00
83615 0% 19 $0.00
99232 Hospital visit by a doctor, follow-up day 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGRIGG, WILLIAM (EXECUTIVE VICE PRESIDENT & CFO)
Parent organizationSOUTHCOAST HEALTH SYSTEM, INC
Same official

Other billing entities under GRIGG, WILLIAM

Full network →
ProviderLocationPaid
Southcoast Hospitals Group, INCNew Bedford, MA$172.80M
Southcoast Hospitals Group, INCFall River, MA$97.65M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.